TB treatment gets a personal touch: new study tests custom dosing

NCT ID NCT06585358

Recruiting now Knowledge-focused Sponsor: Karolinska Institutet Source: ClinicalTrials.gov ↗

First seen Nov 21, 2025 · Last updated Jun 13, 2026 · Updated 26 times

Summary

This observational study aims to see if using a computer model to personalize the doses of standard TB drugs can help patients reach the right drug levels faster. About 30 adults with pulmonary tuberculosis will have their drug levels measured and doses adjusted based on the model's predictions. The goal is to improve treatment by ensuring each patient gets the optimal dose early on.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TUBERCULOSIS, PULMONARY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Karolinska University Hospital
RECRUITING

Stockholm, 17177, Sweden

Contact Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Linköping University Hospital
RECRUITING

Linköping, Sweden

Contact Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

TUBERCULOSIS, PULMONARY